Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock
RVPHOTCPharmaceutical PreparationsFiscal year ends December 31
$0.45−0.02 (-4.36%)
Close on Oct 19, 2026Market cap $5.94MP/E –Yield –
Reviva Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Reviva Pharmaceuticals's total assets was $18.56M at Sep 30, 2026. For fiscal 2025 it was $15.92M, up 2.7% from the year before. The highest annual figure on record is $31.40M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.92M | +2.7% |
| FY2024 | Dec 31, 2024 | $15.50M | -34.6% |
| FY2023 | Dec 31, 2023 | $23.70M | +25.2% |
| FY2022 | Dec 31, 2022 | $18.92M | -39.7% |
| FY2021 | Dec 31, 2021 | $31.40M | +258.4% |
| FY2020 | Dec 31, 2020 | $8.76M | +336910.7% |
| FY2019 | Dec 31, 2019 | $2.60K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $18.56M | +29.5% |
| Q2 FY2026 | Jun 30, 2026 | $21.14M | +81.7% |
| Q1 FY2026 | Mar 31, 2026 | $23.56M | +232.9% |
| Q4 FY2025 | Dec 31, 2025 | $15.92M | +2.7% |
| Q3 FY2025 | Sep 30, 2025 | $14.33M | +87.8% |
| Q2 FY2025 | Jun 30, 2025 | $11.63M | +44.5% |
| Q1 FY2025 | Mar 31, 2025 | $7.08M | -47.6% |
| Q4 FY2024 | Dec 31, 2024 | $15.50M | -34.6% |
| Q3 FY2024 | Sep 30, 2024 | $7.63M | +41.6% |
| Q2 FY2024 | Jun 30, 2024 | $8.05M | -32.0% |
| Q1 FY2024 | Mar 31, 2024 | $13.50M | +4.6% |
| Q4 FY2023 | Dec 31, 2023 | $23.70M | +25.2% |
| Q3 FY2023 | Sep 30, 2023 | $5.39M | -77.6% |
| Q2 FY2023 | Jun 30, 2023 | $11.84M | -42.6% |
| Q1 FY2023 | Mar 31, 2023 | $12.90M | -48.9% |
| Q4 FY2022 | Dec 31, 2022 | $18.92M | -39.7% |
| Q3 FY2022 | Sep 30, 2022 | $24.04M | -29.1% |
| Q2 FY2022 | Jun 30, 2022 | $20.64M | -43.5% |
| Q1 FY2022 | Mar 31, 2022 | $25.27M | +279.5% |
| Q4 FY2021 | Dec 31, 2021 | $31.40M | +258.4% |
| Q3 FY2021 | Sep 30, 2021 | $33.89M | -2.3% |
| Q2 FY2021 | Jun 30, 2021 | $36.53M | +6.0% |
| Q1 FY2021 | Mar 31, 2021 | $6.66M | -80.7% |
| Q4 FY2020 | Dec 31, 2020 | $8.76M | +336910.7% |
| Q3 FY2020 | Nov 30, 2020 | $34.69M | -47.8% |
| Q2 FY2020 | Aug 31, 2020 | $34.48M | -48.0% |
| Q1 FY2020 | May 31, 2020 | $34.46M | -47.8% |
| Q4 FY2019 | Dec 31, 2019 | $2.60K | -100.0% |
| Q3 FY2019 | Nov 30, 2019 | $66.47M | +2.2% |
| Q2 FY2019 | Aug 31, 2019 | $66.27M | – |
| Q1 FY2019 | May 31, 2019 | $65.99M | – |
| Q3 FY2018 | Nov 30, 2018 | $65.34M | – |
| Q2 FY2018 | Aug 31, 2018 | $65.05M | – |
See a number that looks wrong?